Scientists at the Herbert Irving Comprehensive Cancer Center (HICCC) have discovered a key mechanism that makes prostate cancer cells resistant to the latest drugs used to treat them. Their findings, ...

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime. Most of the time, diagnosis happens through ...

A Premier League star has revealed that they are battling an “aggressive” form of prostate cancer. On Thursday (4 December), ...

Experts at SICP 2025 outline how molecular mechanisms and bedside assessments can guide personalised treatment for ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...

Former Newcastle goalkeeper Shaka Hislop said Thursday he has prostate cancer. The 56-year-old Hislop, who also played in the Premier League for West Ham and Portsmouth, said he had been diagnosed ...

JANX007 shows significant PSA reductions and favorable rPFS in mCRPC patients, with a manageable safety profile. The trial identifies 6 mg and 9 mg as optimal doses, balancing safety and efficacy.

FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical ...

Janux Therapeutics' cash runway is about 12 months; dilution is likely, and upcoming data from both JANX007 and JANX008 are ...

This satellite symposium at the European Society for Medical Oncology (ESMO) Congress 2025, chaired by Rana McKay, Professor ...

Combined androgen blockade shows significant survival benefits over single-agent ADT in high-risk prostate cancer, as ...

For thousands of Kenyan men who survive prostate cancer each year, one of the most difficult and less talked about struggles ...